Network meta-analysis to assess the clinical value of PRODUCT X in RRMS.
The client engaged Maple Health Group on follow-on workstream for developing a cost-utility and budget impact model for PRODUCT X in RRMS.
To perform a network meta-analysis for PRODUCT X in relapsing-remitting multiple sclerosis to assess its clinical value.
- Systematic literature review to identify relevant studies.
- Develop a statistical analysis plan.
- Perform a Bayesian network meta-analysis.
- Systematic literature review report (.DOC)
- Statistical analysis plan (.DOC)
- Network meta-analysis results (.PPT)